Groowe Groowe / Newsroom / MIRA
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

MIRA News

MIRA Pharmaceuticals, Inc. Common Stock

Yılın Müslüman Dostu Oteli-The Mira Hong Kong, Miramar Travel ve Türkiye Konsolosluğu ile İkinci Yılında Kültürel Açıdan Zenginleştirici İftar Yemeğine Ev Sahipliği Yapıyor USA - Turkish USA - English

prnewswire.com
MIRA

Women's Health Company Mira Calls for Federal Reform of U.S. Sex Education

prnewswire.com
MIRA

MIRA Pharmaceuticals Initiates Final Cohort of Ketamir-2 Phase 1 Clinical Study as Company Prepares for Phase 2a Study

accessnewswire.com
MIRA

Barjeel Geojit launches India Opportunities Fund

prnewswire.com
GFF MIRA

MIRA Pharmaceuticals Initiates Multiple Ascending Dose (MAD) Phase 1 Study of Oral Ketamir-2 and Selects Chemotherapy-Induced Neuropathic Pain as Lead Phase 2a Indication

accessnewswire.com
MIRA MIRA

MIRA Pharmaceuticals Announces Oral Mira-55 Outperformed Injected Morphine in Normalizing Pain and Reducing Inflammation, Supporting Its Planned IND for Chronic Inflammatory Pain

accessnewswire.com
MIRA MIRA

MIRA Pharmaceuticals Closes Acquisition of SKNY Pharmaceuticals, Expands Pipeline with SKNY-1 for Obesity and Nicotine Addiction

accessnewswire.com
MIRA MIRA

MIRA Pharmaceuticals Announces Favorable Topline Results from Phase 1 SAD Study of Oral Ketamir-2, a Next-Generation Non-Scheduled Ketamine Analog

accessnewswire.com
MIRA MIRA

MIRA Pharmaceuticals Reports Positive PTSD Data Demonstrating Ketamir-2 Restores Normalized Behavior in Stressed Animals

accessnewswire.com
MIRA

MIRA Pharmaceuticals Shareholders Approve Acquisition of SKNY Pharmaceuticals, Advancing Next-Generation Oral Therapeutic for Obesity and Smoking Cessation

accessnewswire.com
MIRA